Inst Diagnosti (INDISA) — Capital Reinvestment Ratio
Latest as of June 2023:
0.20x
Inst Diagnosti (INDISA) has a Capital Reinvestment Ratio of 0.20x as of June 2023, meaning it reinvests 0% of its operating cash flow (CL$8.87 Billion) in capital expenditures (CL$1.74 Billion). See Inst Diagnosti (INDISA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.20x
Capex / Operating Cash Flow
Operating Cash Flow
CL$8.87 Billion
CLP
Capital Expenditures
CL$1.74 Billion
CLP
Data as of
Jun 2023
Most recent filing
Inst Diagnosti Capital Reinvestment Ratio (2014–2021)
This chart tracks Inst Diagnosti's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Inst Diagnosti (2014–2021)
Year-by-year Capital Reinvestment Ratio for Inst Diagnosti from 2014 to 2021. For live market cap and broader valuation context, see market value of Inst Diagnosti.
| Year | Reinvestment Ratio | Operating CF (CLP) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 2.12x | CL$14.83 Billion | CL$31.45 Billion | ▲ +146.2% |
| 2020 | 0.86x | CL$14.46 Billion | CL$12.45 Billion | ▲ +23.4% |
| 2019 | 0.70x | CL$10.66 Billion | CL$7.44 Billion | ▲ +118.0% |
| 2018 | 0.32x | CL$14.75 Billion | CL$4.72 Billion | ▼ -44.8% |
| 2017 | 0.58x | CL$14.89 Billion | CL$8.63 Billion | ▼ -31.0% |
| 2016 | 0.84x | CL$11.57 Billion | CL$9.73 Billion | ▲ +2.9% |
| 2015 | 0.82x | CL$15.05 Billion | CL$12.30 Billion | ▲ +84.0% |
| 2014 | 0.44x | CL$13.58 Billion | CL$6.03 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow